Wanqi Wang

• Appointments

  Date	Position	Institution name
  2024 - 2024	Research Coordinator	University of Adelaide
  2020 - 2023	Higher Degree by Research Candidate	The University of Adelaide

• Language Competencies

  Language	Competency
  Chinese (Mandarin)	Can peer review

• Certifications

  Date	Title	Institution name	Country
  2019	Clinical Education	Flinders University	Australia

• Research Interests

  Cancer Biology and Clinical Oncology Immunology Oncology and Carcinogenesis

• Journals

  Year	Citation
  2024	Jones, D. J., Soundararajan, D., Taylor, N. K., Aimiuwu, O. V., Mathkar, P., Shore, A., . . . Frankel, W. N. (2024). Effective knockdown-replace gene therapy in a novel mouse model of DNM1 developmental and epileptic encephalopathy. MOLECULAR THERAPY, 32(10), 3318-3330. DOI
  2022	Acland, M., Lokman, N. A., Young, C., Anderson, D., Condina, M., Desire, C., . . . Klingler-Hoffmann, M. (2022). Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations. Cancers, 14(11), 1-24. DOI Scopus5 WoS3 Europe PMC5
  2022	Leung, D., Price, Z. K., Lokman, N. A., Wang, W., Goonetilleke, L., Kadife, E., . . . Ahmed, N. (2022). Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism. Journal of Translational Medicine, 20(1), 1-23. DOI Scopus17 WoS7 Europe PMC12
  2021	Wang, W., Lokman, N. A., Noye, T. M., Macpherson, A. M., Oehler, M. K., & Ricciardelli, C. (2021). ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome. Cancer Drug Resistance, 4(2), 485-502. DOI Scopus13 WoS8 Europe PMC10

• Conference Papers

  Year	Citation
  2024	Wang, W. (2024). Abstract 6320: CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. In W. Wang (Ed.), CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. American.
  2024	Wang, W. (2024). Abstract 6320: CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. In W. Wang (Ed.), CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. American.
  2024	Wang, W. (2024). Abstract 6320: CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. In W. Wang (Ed.), CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. American.
  2022	Wang, W., Bandara, V., Lokman, N., Napoli, S., Gundsambuu, B., Oehler, M., . . . Ricciardelli, C. (2022). LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer.. In CANCER RESEARCH Vol. 82 (pp. 2 pages). LA, New Orleans: AMER ASSOC CANCER RESEARCH.
  2022	Wang, W., Bandara, V., Lokman, N., Napoli, S., Gundsambuu, B., Oehler, M., . . . Ricciardelli, C. (2022). LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer. In CANCER RESEARCH Vol. 82 (pp. 2 pages). LA, New Orleans: AMER ASSOC CANCER RESEARCH.
  2021	Wang, W., Zhu, F., & Wen, H. (2021). HIV TESTING PREFERENCE AMONG COLLEGE STUDENTS IN CHINA, AN ONLINE QUALITATIVE STUDY. In ANNALS OF BEHAVIORAL MEDICINE Vol. 55 (pp. S257). OXFORD UNIV PRESS INC.

Research Coordinator from 2024

• Memberships

  Date	Role	Membership	Country
  2022 - ongoing	Member	American Association for Cancer Research	United States
  2022 - ongoing	Member	Australian Society for Medical Research	Australia
  2018 - ongoing	Member	Robinson Research Institute	Australia

• Email: wanqi.wang@adelaide.edu.au